Back
Pluri 10K Form
Sell
36
PLUR
Pluri
Last Price:
$4.82
Seasonality Move:
30.59%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PLUR News And Ratings
See the #1 stock for the next 7 days that we like better than PLUR
PLUR Financial Statistics
Sales & Book Value
| Annual Sales: | $326K |
|---|---|
| Cash Flow: | $-4.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.96 |
| Price / Book: | 291.82 |
Profitability
| EPS (TTM): | -4.12000 |
|---|---|
| Net Income (TTM): | $-21.8M |
| Gross Margin: | $322K |
| Return on Equity: | -438.78% |
| Return on Assets: | -55.22% |
Pluri Earnings Forecast
Key Pluri Financial Ratios
-
The Gross Profit Margin over the past 17 years for PLUR is 98.77%.
-
The Selling, General & Administrative Expenses for PLUR have been equal to 3,077.91% of Gross Profit Margin.
-
The Research & Development expenses have been 3,817.79% of Revenue.
-
The Interest Expense is -4.15% of Operating Income.
-
The Net Earning history of PLUR is -6,407.36% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 15 years.
Pluri Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PLUR |
| Website: | pluri-biotech.com |
Debt
| Debt-to-Equity Ratio: | -4.8 |
|---|---|
| Current Ratio: | 5.9 |
| Quick Ratio: | 5.6 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |